Glenmark gets USFDA nod for generic asthma drug

15 Jul 2010 Evaluate

Glenmark has received the approval of US health regulator USFDA to introduce generic theophylline tablets, used for treating asthma and other lung diseases. Glenmark Generics Inc (GGI) will start marketing and distributing the medicine, in 400mg and 600 mg strengths, with immediate effect.

 

The market for theophylline tablets is estimated to be USD 8 million per annum and GGI expects a successful launch, based on limited competition existing in this niche segment. Theophylline extended-release tablets are indicated for treatment of symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases such as emphysema and chronic bronchitis. crackcrack

Glenmark Pharma Share Price

1622.40 -13.65 (-0.83%)
06-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1846.95
Dr. Reddys Lab 1350.65
Cipla 1490.55
Lupin 2357.75
Zydus Lifesciences 961.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.